211 results on '"Vasudevaraja, Varshini"'
Search Results
2. DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas
3. Molecular correlates of male germ cell tumors with overgrowth of components resembling somatic malignancies
4. Clinicopathologic and molecular spectrum of testicular sex cord-stromal tumors not amenable to specific histopathologic subclassification
5. Genomic and Transcriptomic Analyses of NF1-Mutant Melanoma Identify Potential Targeted Approach for Treatment
6. Deep learning-based classifier for carcinoma of unknown primary using methylation quantitative trait loci.
7. Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors.
8. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition
9. Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples
10. Novel Androgen Receptor Splice Variant 7 in Gynecologic Tumors
11. Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping
12. Revisiting multifocal breast cancer: a clonality study of ductal carcinoma using whole exome sequencing
13. DNA methylation-based classification of sinonasal undifferentiated carcinoma
14. BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor
15. Increased PI3K pathway activity is associated with recurrent breast cancer in patients with low and intermediate 21-gene recurrence score
16. YAP1-FAM118B Fusion Defines a Rare Subset of Childhood and Young Adulthood Meningiomas
17. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors
18. Molecular and clinicopathologic features of gliomas harboring NTRK fusions
19. DNA Methylation Profiles Are Stable in H3 K27M-Mutant Diffuse Midline Glioma Neurosphere Cell Lines.
20. DNA methylation signature of synchronous endometrioid endometrial and ovarian carcinomas
21. Ganglioglioma in a Survivor of Infantile Glioblastoma
22. Functional and topographic effects on DNA methylation in IDH1/2 mutant cancers
23. Racial distribution of molecularly classified brain tumors.
24. The Prognostic Impact of Subclonal IDH1 Mutation in Grade 2-4 Astrocytomas
25. Supplementary Data from Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming
26. Supp Table 1 from Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming
27. Data from Innate αβ T Cells Mediate Antitumor Immunity by Orchestrating Immunogenic Macrophage Programming
28. Supplementary Data from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements
29. Supplementary Figure from DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome
30. Supplementary Figure from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements
31. Supplementary Figures S1, S2 from Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma
32. Supplementary Data from DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome
33. Data from Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements
34. Supplementary Tables S1-S4 from Cell Surface Notch Ligand DLL3 is a Therapeutic Target in Isocitrate Dehydrogenase–mutant Glioma
35. PMTDS: a computational method based on genetic interaction networks for Precision Medicine Target-Drug Selection in cancer
36. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors—A prospective study and guidelines for clinical testing
37. Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma
38. Clinical, Pathological, and Molecular Characteristics of Diffuse Spinal Cord Gliomas
39. DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome
40. Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements
41. Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma
42. NCOG-11. ASSOCIATION OF HYPERGLYCEMIA AND TUMOR SUBCLASS ON SURVIVAL IN IDH-WILDTYPE GLIOBLASTOMA
43. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer
44. Additional file 1 of Spatial progression and molecular heterogeneity of IDH-mutant glioblastoma determined by DNA methylation-based mapping
45. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies
46. Somatic Focal Copy Number Gains of Noncoding Regions of Receptor Tyrosine Kinase Genes in Treatment-Resistant Epilepsy
47. WNT-Activated Medulloblastomas With Hybrid Molecular Subtypes
48. Abstract PR04: Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis
49. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
50. Author response: Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.